111 related articles for article (PubMed ID: 32735728)
1. Identification of three predictors of gastric cancer progression and prognosis.
Huang K; Chen S; Xie R; Jiang P; Yu C; Fang J; Liu X; Yu F
FEBS Open Bio; 2020 Sep; 10(9):1891-1899. PubMed ID: 32735728
[TBL] [Abstract][Full Text] [Related]
2. Tripeptidyl peptidase I promotes human endometrial epithelial cell adhesive capacity implying a role in receptivity.
Santos LL; Ling CK; Dimitriadis E
Reprod Biol Endocrinol; 2020 Dec; 18(1):124. PubMed ID: 33317560
[TBL] [Abstract][Full Text] [Related]
3. The transcription factor RFX5 is a transcriptional activator of the TPP1 gene in hepatocellular carcinoma.
Zhao Y; Xie X; Liao W; Zhang H; Cao H; Fei R; Wang X; Wei L; Shao Q; Chen H
Oncol Rep; 2017 Jan; 37(1):289-296. PubMed ID: 27840983
[TBL] [Abstract][Full Text] [Related]
4. A novel CLN2/TPP1 mutation in a patient with late infantile neuronal ceroid lipofuscinosis.
Yu F; Liu XM; Chen YH; Zhang SQ; Wang K
Neurol Sci; 2015 Oct; 36(10):1917-9. PubMed ID: 26032578
[No Abstract] [Full Text] [Related]
5. Global Brain Transcriptome Analysis of a Tpp1 Neuronal Ceroid Lipofuscinoses Mouse Model.
Domowicz MS; Chan WC; Claudio-Vázquez P; Henry JG; Ware CB; Andrade J; Dawson G; Schwartz NB
ASN Neuro; 2019; 11():1759091419843393. PubMed ID: 31003587
[TBL] [Abstract][Full Text] [Related]
6. Mutation update: Review of TPP1 gene variants associated with neuronal ceroid lipofuscinosis CLN2 disease.
Gardner E; Bailey M; Schulz A; Aristorena M; Miller N; Mole SE
Hum Mutat; 2019 Nov; 40(11):1924-1938. PubMed ID: 31283065
[TBL] [Abstract][Full Text] [Related]
7. AAV gene transfer delays disease onset in a TPP1-deficient canine model of the late infantile form of Batten disease.
Katz ML; Tecedor L; Chen Y; Williamson BG; Lysenko E; Wininger FA; Young WM; Johnson GC; Whiting RE; Coates JR; Davidson BL
Sci Transl Med; 2015 Nov; 7(313):313ra180. PubMed ID: 26560358
[TBL] [Abstract][Full Text] [Related]
8. Partial genetic suppression of a loss-of-function mutant of the neuronal ceroid lipofuscinosis-associated protease TPP1 in Dictyostelium discoideum.
Phillips JE; Gomer RH
Dis Model Mech; 2015 Feb; 8(2):147-56. PubMed ID: 25540127
[TBL] [Abstract][Full Text] [Related]
9. Inducible transgenic expression of tripeptidyl peptidase 1 in a mouse model of late-infantile neuronal ceroid lipofuscinosis.
Nemtsova Y; Wiseman JA; El-Banna M; Lobel P; Sleat DE
PLoS One; 2018; 13(2):e0192286. PubMed ID: 29408933
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analysis of lncRNAs Associated with the Pathogenesis and Prognosis of Gastric Cancer.
Zhang X; Jiang Y; Xie Y; Leng X; Song F
DNA Cell Biol; 2020 Feb; 39(2):299-309. PubMed ID: 31934786
[TBL] [Abstract][Full Text] [Related]
11. Multifocal retinopathy in Dachshunds with CLN2 neuronal ceroid lipofuscinosis.
Whiting RE; Pearce JW; Castaner LJ; Jensen CA; Katz RJ; Gilliam DH; Katz ML
Exp Eye Res; 2015 May; 134():123-32. PubMed ID: 25697710
[TBL] [Abstract][Full Text] [Related]
12. Intracerebroventricular gene therapy that delays neurological disease progression is associated with selective preservation of retinal ganglion cells in a canine model of CLN2 disease.
Whiting REH; Jensen CA; Pearce JW; Gillespie LE; Bristow DE; Katz ML
Exp Eye Res; 2016 May; 146():276-282. PubMed ID: 27039708
[TBL] [Abstract][Full Text] [Related]
13. Autosomal recessive spinocerebellar ataxia 7 (SCAR7) is caused by variants in TPP1, the gene involved in classic late-infantile neuronal ceroid lipofuscinosis 2 disease (CLN2 disease).
Sun Y; Almomani R; Breedveld GJ; Santen GW; Aten E; Lefeber DJ; Hoff JI; Brusse E; Verheijen FW; Verdijk RM; Kriek M; Oostra B; Breuning MH; Losekoot M; den Dunnen JT; van de Warrenburg BP; Maat-Kievit AJ
Hum Mutat; 2013 May; 34(5):706-13. PubMed ID: 23418007
[TBL] [Abstract][Full Text] [Related]
14. Extraneuronal pathology in a canine model of CLN2 neuronal ceroid lipofuscinosis after intracerebroventricular gene therapy that delays neurological disease progression.
Katz ML; Johnson GC; Leach SB; Williamson BG; Coates JR; Whiting REH; Vansteenkiste DP; Whitney MS
Gene Ther; 2017 Apr; 24(4):215-223. PubMed ID: 28079862
[TBL] [Abstract][Full Text] [Related]
15. Intrathecal tripeptidyl-peptidase 1 reduces lysosomal storage in a canine model of late infantile neuronal ceroid lipofuscinosis.
Vuillemenot BR; Katz ML; Coates JR; Kennedy D; Tiger P; Kanazono S; Lobel P; Sohar I; Xu S; Cahayag R; Keve S; Koren E; Bunting S; Tsuruda LS; O'Neill CA
Mol Genet Metab; 2011 Nov; 104(3):325-37. PubMed ID: 21784683
[TBL] [Abstract][Full Text] [Related]
16. Modelling of Neuronal Ceroid Lipofuscinosis Type 2 in
Smith PK; Sen MG; Fisher PR; Annesley SJ
Cells; 2019 May; 8(5):. PubMed ID: 31100984
[TBL] [Abstract][Full Text] [Related]
17. Clinical study in Chinese patients with late-infantile form neuronal ceroid lipofuscinoses.
Chang X; Huang Y; Meng H; Jiang Y; Wu Y; Xiong H; Wang S; Qin J
Brain Dev; 2012 Oct; 34(9):739-45. PubMed ID: 22245569
[TBL] [Abstract][Full Text] [Related]
18. A zebrafish model of CLN2 disease is deficient in tripeptidyl peptidase 1 and displays progressive neurodegeneration accompanied by a reduction in proliferation.
Mahmood F; Fu S; Cooke J; Wilson SW; Cooper JD; Russell C
Brain; 2013 May; 136(Pt 5):1488-507. PubMed ID: 23587805
[TBL] [Abstract][Full Text] [Related]
19. CLN2 Disease (Classic Late Infantile Neuronal Ceroid Lipofuscinosis).
Kohlschütter A; Schulz A
Pediatr Endocrinol Rev; 2016 Jun; 13 Suppl 1():682-8. PubMed ID: 27491216
[TBL] [Abstract][Full Text] [Related]
20. Protracted late infantile ceroid lipofuscinosis due to TPP1 mutations: Clinical, molecular and biochemical characterization in three sibs.
Di Giacopo R; Cianetti L; Caputo V; La Torraca I; Piemonte F; Ciolfi A; Petrucci S; Carta C; Mariotti P; Leuzzi V; Valente EM; D'Amico A; Bentivoglio A; Bertini E; Tartaglia M; Zampino G
J Neurol Sci; 2015 Sep; 356(1-2):65-71. PubMed ID: 26143525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
